N
Neal L. Benowitz
Researcher at University of California, San Francisco
Publications - 825
Citations - 66786
Neal L. Benowitz is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Nicotine & Cotinine. The author has an hindex of 126, co-authored 792 publications receiving 60658 citations. Previous affiliations of Neal L. Benowitz include Shaare Zedek Medical Center & University College London.
Papers
More filters
Journal ArticleDOI
Metabolism and Disposition Kinetics of Nicotine
TL;DR: Current knowledge about the metabolism and disposition kinetics of nicotine, some other naturally occurring tobacco alkaloids, and nicotine analogs that are under development as potential therapeutic agents are reviewed.
Journal ArticleDOI
Levels of selected carcinogens and toxicants in vapour from electronic cigarettes
Maciej L. Goniewicz,Maciej L. Goniewicz,Maciej L. Goniewicz,Jakub Knysak,Michal Gawron,Leon Kosmider,Andrzej Sobczak,Jolanta Kurek,Adam Prokopowicz,Magdalena Jabłońska-Czapla,Czesława Rosik-Dulewska,Christopher Havel,Peyton Jacob,Neal L. Benowitz +13 more
TL;DR: The findings of this study are consistent with the idea that substituting tobacco cigarettes with e-cigarettes may substantially reduce exposure to selected tobacco-specific toxicants.
Book ChapterDOI
Nicotine Chemistry, Metabolism, Kinetics and Biomarkers
TL;DR: The current optimal plasma cotinine cut-point to distinguish smokers from non-smokers in the general US population is 3 ng ml(-1), which is much lower than that established 20 years ago, reflecting less secondhand smoke exposure due to clear air policies and more light or occasional smoking.
Journal ArticleDOI
Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction.
TL;DR: NICOTINE has been consumed in the form of tobacco and other plants for many hundreds of years and has become available as a pharmaceutical agent, marketed as a chewing gum to help people stop smoking.
Journal ArticleDOI
E-Cigarettes: A Scientific Review
TL;DR: E-cigarette products are changing quickly, and many of the findings from studies of older products may not be relevant to the assessment of newer products that could be safer and more effective as nicotine delivery devices, so patterns of use and the ultimate impact on public health may differ.